Literature DB >> 28049176

Applicability of the World Health Organization recommended new shorter regimen in a multidrug-resistant tuberculosis high burden country.

Arshad Javaid1, Nafees Ahmad2,3, Amer Hayat Khan4, Zubair Shaheen5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28049176     DOI： 10.1183/13993003.01967-2016

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  8 in total

1.  The shorter multidrug-resistant tuberculosis treatment regimen in Singapore: are patients from South-East Asia eligible?

Authors:  Cynthia B E Chee; Kyi-Win KhinMar; Li-H Sng; Roland Jureen; Jeffery Cutter; Vernon J M Lee; Yee-Tang Wang
Journal:  Eur Respir J       Date:  2017-08-10       Impact factor: 16.671

2.  Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.

Authors:  Payam Nahid; Sundari R Mase; Giovanni Battista Migliori; Giovanni Sotgiu; Graham H Bothamley; Jan L Brozek; Adithya Cattamanchi; J Peter Cegielski; Lisa Chen; Charles L Daley; Tracy L Dalton; Raquel Duarte; Federica Fregonese; C Robert Horsburgh; Faiz Ahmad Khan; Fayez Kheir; Zhiyi Lan; Alfred Lardizabal; Michael Lauzardo; Joan M Mangan; Suzanne M Marks; Lindsay McKenna; Dick Menzies; Carole D Mitnick; Diana M Nilsen; Farah Parvez; Charles A Peloquin; Ann Raftery; H Simon Schaaf; Neha S Shah; Jeffrey R Starke; John W Wilson; Jonathan M Wortham; Terence Chorba; Barbara Seaworth
Journal:  Am J Respir Crit Care Med       Date:  2019-11-15       Impact factor: 21.405

3.  Validity of Time to Sputum Culture Conversion to Predict Cure in Patients with Multidrug-Resistant Tuberculosis: A Retrospective Single-Center Study.

Authors:  Arshad Javaid; Nafees Ahmad; Afsar Khan Afridi; Anila Basit; Amer Hayat Khan; Izaz Ahmad; Muhammad Atif
Journal:  Am J Trop Med Hyg       Date:  2018-03-29       Impact factor: 2.345

4.  Few eligible for the newly recommended short course MDR-TB regimen at a large Mumbai private clinic.

Authors:  Zarir F Udwadia; Jeffrey A Tornheim; Shashank Ganatra; Andrea DeLuca; Camilla S Rodrigues; Amita Gupta
Journal:  BMC Infect Dis       Date:  2019-01-28       Impact factor: 3.090

5.  Prognostic accuracy of time to sputum culture conversion in predicting cure in extensively drug-resistant tuberculosis patients: a multicentre retrospective observational study.

Authors:  Muhammad Abubakar; Nafees Ahmad; Muhammad Atif; Izaz Ahmad; Abdul Wahid; Asad Khan; Fahad Saleem; Abdul Ghafoor
Journal:  BMC Infect Dis       Date:  2022-03-02       Impact factor: 3.090

6.  High rate of successful treatment outcomes among childhood rifampicin/multidrug-resistant tuberculosis in Pakistan: a multicentre retrospective observational analysis.

Authors:  Farah Naz; Nafees Ahmad; Abdul Wahid; Izaz Ahmad; Asad Khan; Muhammad Abubakar; Shabir Ahmed Khan; Amjad Khan; Abdullah Latif; Abdul Ghafoor
Journal:  BMC Infect Dis       Date:  2021-12-04       Impact factor: 3.090

7.  Comparative effectiveness of individualized longer and standardized shorter regimens in the treatment of multidrug resistant tuberculosis in a high burden country.

Authors:  Abdul Wahid; Abdul Ghafoor; Abdul Wali Khan; Yaser Mohammed Al-Worafi; Abdullah Latif; Nisar Ahmed Shahwani; Muhammad Atif; Fahad Saleem; Nafees Ahmad
Journal:  Front Pharmacol       Date:  2022-09-06       Impact factor: 5.988

8.  Predictors of unsuccessful interim treatment outcomes of multidrug resistant tuberculosis patients.

Authors:  Muhammad Atif; Arslan Bashir; Nafees Ahmad; Razia Kaneez Fatima; Sehar Saba; Shane Scahill
Journal:  BMC Infect Dis       Date:  2017-09-29       Impact factor: 3.090
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.